Abstract:Purpose Angiogenesis is an indispensable process during tumor development. The currently accepted standard method for quantifying tumor angiogenesis is to assess microvessel density (MVD) based on CD105 staining, which is an independent prognostic factor for survival in patients with most solid tumor types. The goal of this study is to evaluate tumor angiogenesis in a mouse model by near-infrared fluorescence (NIRF) imaging of CD105 expression. Methods TRC105, a human/murine chimeric anti-CD105 monoclonal antibody, was conjugated to an NIRF dye (IRDye 800CW; Ex: 778 nm; Em: 806 nm). FACS analysis and microscopy studies were performed to compare the CD105 binding affinity of TRC105 and 800CW-TRC105. In vivo/ex vivo NIRF imaging, blocking studies, and ex vivo histology were performed on 4T1 murine breast tumor-bearing mice to evaluate the ability of 800CW-TRC105 to target tumor angiogenesis. Another chimeric antibody, cetuximab, was used as an isotype-matched control. Results FACS analysis of human umbilical vein endothelial cells (HUVECs) revealed no difference in CD105 binding affinity between TRC105 and 800CW-TRC105, which was further validated by fluorescence microscopy. 800CW conjugation of TRC105 was achieved in excellent yield (> 85%), with an average of 0.4 800CW molecules per TRC105. Serial NIRF imaging after intravenous injection of 800CW-TRC105 revealed that the 4T1 tumor could be clearly visualized as early as 30 min post-injection. Quantitative region of interest (ROI) analysis showed that the tumor uptake peaked at about 16 h post-injection. Based on ex vivo NIRF imaging at 48 h post-injection, tumor uptake of 800CW-TRC105 was higher than most organs, thus providing excellent tumor contrast. Blocking experiments, control studies with 800CW-cetuximab and 800CW, as well as ex vivo histology all confirmed the in vivo target specificity of 800CW-TRC105. Conclusion This is the first successful NIRF imaging study of CD105 expression in vivo. Fast, prominent, persistent, and CD105-specific uptake of the probe during tumor angiogenesis was observed in a mouse model. 800CW-TRC105 may be used in the clinic for imaging tumor angiogenesis within the lesions close to the skin surface, tissues accessible by endoscopy, or during image-guided surgery.

Tumor-specific Fluorescence Activation of Rhodamine Isothiocyanate Derivatives.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

High‐Performance Red/Near‐IR Carbon Dots As Fluorescence Probes for Tumor Imaging in Vivo

Tumor-Targeted Fluorescence Imaging and Mechanisms of Tumor Cell-Derived Carbon Nanodots

Synthesis and properties of an efficient tumor cells-interacting fluorescent probe derived from rhodamine B

A Novel Nitro-Substituted Benzothiadiazole As Fluorescent Probe for Tumor Cells under Hypoxic Condition

Bioorthogonally activatable cyanine dye with torsion-induced disaggregation for in vivo tumor imaging

NIR AIE luminogens for primary and metastasis tumor imaging and tracing applications

Glutathione-responsive Disassembly of Disulfide Dicyanine for Tumor Imaging with Reduction in Background Signal Intensity

Design, synthesis, cell imaging, and bioactivity assessment of novel rhodamine-pyrimidine nido- carborane derivatives as fluorescent anticancer agents

Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.

Near IR Heptamethine Cyanine Dye-Mediated Cancer Imaging

Rapid and Accurate Tumor-Target Bio-Imaging Through Specific in Vivo Biosynthesis of a Fluorescent Europium Complex.

In Vivo Near-Infrared Fluorescence Imaging of CD105 Expression During Tumor Angiogenesis

Fluorescent and Quantitative Mitochondrial Redox Imaging of Tumor Targeted by Octa-RGD Probe

Phosphorescent Light-Emitting Iridium Complexes Serve As A Hypoxia-Sensing Probe for Tumor Imaging in Living Animals

Synthesis of Dimeric Cyclic RGD Based Near-Infrared Probe for in Vivo Tumor Diagnosis

Functionalized Near-Infrared Quantum Dots For In Vivo Tumor Vasculature Imaging

Imaging Tumor Angiogenesis in Breast Cancer Experimental Lung Metastasis with Positron Emission Tomography, Near-Infrared Fluorescence, and Bioluminescence

Color-Convertible, Unimolecular, Micelle-Based, Activatable Fluorescent Probe for Tumor-Specific Detection and Imaging in Vitro and in Vivo

Tumor-Targeted Multimodal Optical Imaging with Versatile Cadmium-Free Quantum Dots.